Penumbra, Inc.
PENNYSEHealthcareMedical Devices
As of Oct 15, 2026 close
- Market cap
- $12.71B
- P/E (TTM)
- 79.15
- Forward P/E
- 72.58
- Dividend yield
- -
- 52-week range
- $221.26$362.41
- Volume (live)
- -
- Avg. volume (3M)
- 360.89K
Penumbra (PEN) Stock Price & Financial Analysis
Penumbra Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $320.09 - $322.17 |
|---|---|
| 52-Week High | $362.41 |
| 52-Week Low | $221.26 |
| Open | $322.13 |
| Volume (last close) | 345.44K |
| Average Volume (3M) | 360.89K |
| Revenue (TTM) | 1.50B |
|---|---|
| Net Income (TTM) | 160.59M |
| Free Cash Flow (TTM) | 215.91M |
| EPS (TTM) | $4.07 |
| Profit Margin | 10.67% |
| Operating Margin | 12.45% |
| Return on Equity (ROE) | 10.49% |
| Debt to Equity | 0.14 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 12.71B |
|---|---|
| Shares Outstanding | 39.57M |
| P/E Ratio (TTM) | 79.15 |
| Forward P/E | 72.58 |
| Price to Sales (P/S) | 8.45 |
| Price to Book (P/B) | 8.30 |
| EV/EBITDA | 57.22 |
| 50-Day MA | $321.26 |
|---|---|
| 200-Day MA | $326.98 |
| 1-Year Change | +26.54% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Penumbra at a Glance
As of the Oct 15, 2026 close, Penumbra (PEN) has a market capitalization of $12.71B. The stock trades at 79.2× trailing earnings, 72.6× forward earnings and 8.4× sales. Over the trailing twelve months it earned $160.59M on revenue of $1.50B (a 10.7% profit margin) and generated $215.91M of free cash flow. Revenue grew 17.6% year over year.
As of its latest reported balance sheet, it holds $205.27M in cash and securities against $212.71M of debt, a net debt position of $7.44M.
Penumbra does not currently pay a dividend.
The share price is up 26.5% over the past year. At $321.20 (the Oct 15, 2026 close) it sits within its 52-week range of $221.26 to $362.41, below its 200-day moving average of $326.98.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $368.00, 14.6% above the Oct 15, 2026 close.
Frequently Asked Questions About Penumbra
What is the current stock price for PEN?
As of the Oct 15, 2026 close, PEN stock trades at $321.20. The 52-week range is $221.26–$362.41, with a day range of $320.09–$322.17.
What is the P/E ratio for PEN?
As of the Oct 15, 2026 close, Penumbra's trailing twelve-month (TTM) P/E ratio is 79.2, meaning investors pay $79.2 for every $1 of annual earnings. The forward P/E is 72.6, reflecting analyst expectations for future earnings. Penumbra operates in the Healthcare sector.
Does PEN pay dividends?
Penumbra does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PEN?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for PEN is Hold. The average 12-month price target is $368.00, a 14.6% upside from the Oct 15, 2026 close of $321.20.
What is the market cap of PEN?
As of the Oct 15, 2026 close, Penumbra's market capitalization is $12.71B, classifying it as a large-cap company. Penumbra operates in the Healthcare sector within the Medical Devices industry.